Literature DB >> 8732288

Possible role of nitric oxide in the development of L-2-chloropropionic acid-induced cerebellar granule cell necrosis.

P S Widdowson1, A Gyte, M G Simpson, M Farnworth, D Dunn, R B Moore, I Wyatt, E A Lock.   

Abstract

1. L-2-Chloropropionic acid (L-CPA) produces selective neuronal cell necrosis in rat cerebellum when administered orally at 750 mg kg-1 that is mediated in part through activation of N-methyl-D-aspartate (NMDA) receptors. Cerebellar granule cell death occurs between 30 and 36 h following L-CPA administration exhibiting a number of features in common with excitatory amino acid-induced cell death. We have used this in vivo model to examine the neurochemical processes following L-CPA-induced activation of NMDA receptors leading to neuronal cell death in the rat cerebellum. 2. The effects of a number of compounds which potently block nitric oxide synthase in vitro were examined on L-CPA-induced neurotoxicity 48 h following L-CPA dosing, to discover whether the neuronal cell death is mediated in part by excessive nitric oxide generation. Four inhibitors were studied, NG-nitro-L-arginine (L-NOARG), NG-nitro-L-arginine methyl ester (L-NAME), NG-iminoethyl-L-ornithine (L-NIO) and 3-bromo-7-nitroindazole (BrNI). 3. L-NAME (50 mg kg-1, i.p. twice daily) and BrIN (50 mg kg-1, i.p. twice daily) administration prevented the L-CPA-induced loss of granule cells which can reach up to 80-90% of the total cell number in rats treated with L-CPA alone. L-NOARG (50 mg kg-1, i.p. twice daily) and L-NIO administered at either 25 or 100 mg kg-1, twice daily did not produce any significant protection against L-CPA-induced neurotoxicity. 4. Both L-NAME and BrIN also prevented the L-CPA-induced increase in cerebellar water content and sodium concentrations. L-NIO when administered at the highest doses prevented the increase in cerebellar sodium concentration but not water content. L-NIO and L-NOARG were ineffective in preventing the L-CPA-induced increases in cerebellar water and sodium concentrations. 5. L-CPA-induced reductions in cerebellar aspartate and glutamate concentrations and increases in glutamine and GABA concentrations were prevented by L-NAME and BrIn, but not by L-NIO or L-NOARG. Also reductions in L-[3H]-glutamate binding to glutamate ionotrophic and metabotrophic receptors in the granule cell layer of rat cerebellum was prevented by L-NAME and BrIN, but not L-NIO or L-NOARG. 6. In conclusion, the neuroprotection offered by L-NAME and BrIN suggests that L-CPA-induced cerebellar granule cell necrosis is possibly mediated by or associated with excessive generation of nitric oxide. The inability of nitric oxide synthase inhibitors, L-NOARG and L-NIO to afford protection may result from their limited penetration into the brain (L-NIO) or rapid dissociation from the enzyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8732288      PMCID: PMC1909562          DOI: 10.1111/j.1476-5381.1996.tb15351.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Synaptic activation of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors in the mossy fibre pathway in adult and immature rat cerebellar slices.

Authors:  J Garthwaite; A R Brodbelt
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

2.  Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.

Authors:  D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 3.  Glutamate neurotoxicity and diseases of the nervous system.

Authors:  D W Choi
Journal:  Neuron       Date:  1988-10       Impact factor: 17.173

4.  L-[3H]Glutamate binds to kainate-, NMDA- and AMPA-sensitive binding sites: an autoradiographic analysis.

Authors:  D T Monaghan; D Yao; C W Cotman
Journal:  Brain Res       Date:  1985-08-12       Impact factor: 3.252

5.  Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results.

Authors:  M Salter; C Duffy; R Hazelwood
Journal:  Neuropharmacology       Date:  1995-03       Impact factor: 5.250

6.  Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles.

Authors:  R C Babbedge; P A Bland-Ward; S L Hart; P K Moore
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects.

Authors:  P K Moore; P Wallace; Z Gaffen; S L Hart; R C Babbedge
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

8.  Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by the novel monosodium salt of 7-nitro indazole.

Authors:  M T Silva; S Rose; J G Hindmarsh; G Aislaitner; J W Gorrod; P K Moore; P Jenner; C D Marsden
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

9.  Malonate produces striatal lesions by indirect NMDA receptor activation.

Authors:  R Henshaw; B G Jenkins; J B Schulz; R J Ferrante; N W Kowall; B R Rosen; M F Beal
Journal:  Brain Res       Date:  1994-05-30       Impact factor: 3.252

10.  Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate.

Authors:  J G Greene; J T Greenamyre
Journal:  J Neurochem       Date:  1995-01       Impact factor: 5.372

View more
  1 in total

1.  Evidence for mediation of L-2-chloropropionic acid-induced delayed neuronal cell death by activation of a constitutive nitric oxide synthase.

Authors:  P S Widdowson; M Farnworth; R B Moore; D Dunn; I Wyatt
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.